The Patent Finder

SK Biopharmaceuticals Co., Ltd.

81 patents currently held · Updated Nov 21, 2026
17 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

29
Ending by 2030
Apr 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Dec 11 to 30, 2026 · next Dec 11
  • 2 fees due Feb 8 to 15, 2027 · next Feb 8
  • 3 fees due Apr 20 to 29, 2027 · next Apr 20
  • 1 fee due May 26, 2027
    The maintenance fee for Aminocarbonylcarbamate Compounds (US 10,485,781) comes due May 26, 2027. Unpaid by Nov 26, 2027, it lapses early.
  • 1 fee due Jun 17, 2027
    The maintenance fee for Methods for treating or preventing fatigue using O-carbamoyl-phenylalaninol compounds (US 10,507,192) comes due Jun 17, 2027. Unpaid by Dec 17, 2027, it lapses early.
  • 2 fees due Jul 12 to 19, 2027 · next Jul 12
  • 2 fees due Sep 1 to 22, 2027 · next Sep 1
  • 1 fee due Oct 7, 2027
    The maintenance fee for Method for Preparing Aryl 2-Tetrazol-2-YL Ketone with Improved Selectivity (US 10,611,737) comes due Oct 7, 2027. Unpaid by Apr 7, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 23, 2026
  • 4 terms have ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,901,116Method for treating pain, anxiety or depression using carbamoyloxy alkanoyl piperazine compound
In force
 · USPTO record
In forceUSPTO record
US 7,985,752Phenyl piperazine compounds, pharmaceutical composition including the same and use thereof
In force
 · USPTO record
In forceUSPTO record
US 8,552,060Methods for treatment of sexual dysfunction
In force
 · USPTO record
In forceUSPTO record
US 7,964,605Phenyl piperazine compounds, pharmaceutical composition comprising the same, and use thereof
In force
 · USPTO record
In forceUSPTO record
US 10,201,519Stabilized pediatric suspension of carisbamate
In force
 · USPTO record
In forceUSPTO record
US 8,541,409Carbamoyloxy arylalkanoyl arylpiperazine analgesics
In force
 · USPTO record
In forceUSPTO record
US 8,513,2853 or 4-substituted piperidine compounds
In force
 · USPTO record
In forceUSPTO record
US 8,592,406Transnasal anticonvulsive pharmaceutical composition comprising poorly soluble anticonvulsant
In force
 · USPTO record
In forceUSPTO record
US 9,161,913Stabilized pediatric suspension of carisbamate
In force
 · USPTO record
In forceUSPTO record
US 9,676,718Piperidine compounds, pharmaceutical composition comprising the same and its use
In force
 · USPTO record
In forceUSPTO record
10 of 81 patents shown.
Pro members see all 81.
Pro members: see all 81 patents
Also on record, not counted in the 81: 17 patents in force now held by others · 29 lapsed for an unpaid fee · 21 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

19 pending · 8 abandoned · 18 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited